arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1811.07693cs.SE
收藏

制药行业的数据合规性、协调业务和信息系统的互操作性

Data Compliance in Pharmaceutical Industry, Interoperability to align Business and Information Systems

Néjib Moalla, Abdelaziz Bouras, Gilles Neubert, Yacine Ouzrout

摘要:

制药行业的最终目标是产品质量。然而,这种质量可以通过使用许多异构的信息系统来改变,这些信息系统在产品的生命周期中具有不同的业务结构和概念。因此,需要互操作性来保证不同产品数据之间的某种对应性和合规性。在本文中,我们专注于一个特定的合规性问题,生产技术数据,在ERP中表示,和相应的监管指令和规范,代表的上市许可(MA)。MA详细说明了根据食品和药物管理局(FDA)和人用药品委员会(CHMP)等卫生组织规定的要求生产药物的过程。所提出的方法使用的互操作性框架,这是基于组织方面,业务交易和信息技术之间的多层分离,为每个涉及到的实体到所使用的系统之间的通信。

英文摘要:

The ultimate goal in the pharmaceutical sector is product quality. However this quality can be altered by the use of a number of heterogeneous information systems with different business structures and concepts along the lifecycle of the product. Interoperability is then needed to guarantee a certain correspondence and compliance between different product data. In this paper we focus on a particular compliance problem, between production technical data, represented in an ERP, and the corresponding regulatory directives and specifications, represented by the Marketing Authorizations (MA). The MA detail the process for manufacturing the medicine according to the requirements imposed by health organisations such as Food and Drug Administration (FDA) and Committee for Medicinal Products for Human use (CHMP). The proposed approach uses an interoperability framework which is based on a multi-layer separation between the organisational aspects, business trades, and information technologies for each involved entity into the communication between the used systems.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑